WS #12201
Eli Lilly to acquire AtaiBeckley for up to $3.8 billion, a 40% premium, signaling consolidation in the psychedelic therapeutics space.
Eli Lilly to Acquire AtaiBeckley
Eli Lilly to acquire AtaiBeckley for up to $3.8 billion, a 40% premium, signaling consolidation in the psychedelic therapeutics space.